Filing Details
- Accession Number:
- 0001181431-11-020584
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-03-29 18:32:29
- Reporting Period:
- 2011-03-25
- Filing Date:
- 2011-03-29
- Accepted Time:
- 2011-03-29 17:32:29
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1086467 | Drugstore Com Inc | DSCM | Retail-Drug Stores And Proprietary Stores (5912) | 043416255 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1384516 | Lawrence David Lonczak | C/O Drugstore.com, Inc. 411 108Th Ave Ne, Ste 1400 Bellevue WA 98004 | Vp, Chief Marketing Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2011-03-25 | 77,142 | $2.54 | 221,620 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2011-03-25 | 77,142 | $3.90 | 144,478 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2011-03-25 | 50,000 | $2.68 | 194,478 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2011-03-25 | 50,000 | $3.90 | 144,478 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2011-03-25 | 77,142 | $3.90 | 77,142 | $2.54 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2011-03-25 | 50,000 | $3.90 | 50,000 | $2.68 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 22,858 | 2007-03-11 | 2017-04-09 | No | 4 | M | Direct |
| 125,000 | 2008-02-15 | 2018-02-15 | No | 4 | M | Direct |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 05/28/2010.
- This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 05/28/2010.
- This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 05/28/2010.
- This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 05/28/2010.
- This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 05/28/2010.
- Indicates vesting commencement date; the stock option becomes exercisable as to the option's original share total over 48 months, at the rate of 20% six months from the vesting commencement date and the remaining 80% vesting in equal increments at the end of each quarterly period thereafter.
- This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 05/28/2010.
- Indicates vesting commencement date; the stock option becomes exercisable as to the option's original share total over 48 months, at the rate of 20% six months from the vesting commencement date and the remaining 80% vesting in equal increments at the end of each quarterly period thereafter.
Billionaire Hedge Funds
